New drug could free tumor patients from IV sugar drip
NCT ID NCT06881992
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 26 times
Summary
This study tests a new medicine called ersodetug for people whose tumors cause dangerously low blood sugar that standard treatments can't control. About 16 adults will receive the drug alongside their usual care. The main goal is to see if it reduces or eliminates the need for intravenous (IV) sugar infusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUMOR HYPERINSULINISM (TUMOR HI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Investigative Site
NOT_YET_RECRUITINGChicago, Illinois, 60637, United States
-
Investigative Site
NOT_YET_RECRUITINGBethesda, Maryland, 20892, United States
-
Investigative Site
RECRUITINGBoston, Massachusetts, 02114, United States
-
Investigative Site
RECRUITINGRochester, Minnesota, 55905, United States
-
Investigative Site
RECRUITINGNew York, New York, 10021, United States
-
Investigative Site
RECRUITINGCanton, Ohio, 44718, United States
-
Investigative Site
RECRUITINGPortland, Oregon, 97239, United States
-
Investigative Site
NOT_YET_RECRUITINGHouston, Texas, 77030, United States
-
Investigative Site
RECRUITINGClichy, Île-de-France Region, 92110, France
-
Investigative Site
NOT_YET_RECRUITINGRotterdam, South Holland, 3015, Netherlands
-
Investigative Site
RECRUITINGBasel, Canton Basel-Stadt, CH-4001, Switzerland
-
Investigative Site
NOT_YET_RECRUITINGSaint Johns Wood, London, NW3 2QG, United Kingdom
-
Investigative Site
RECRUITINGWithington, Manchester, M20 4BX, United Kingdom
Conditions
Explore the condition pages connected to this study.